DarioHealth
DRIO | NASDAQ
$1.15
-$0.11 (-8.73%)
At close: Nov 16, 2026, 4:00 PM ET
$1.20
+$0.05 (+4.35%)
After-hours:
Nov 16, 2026, 7:13 PM ET
DarioHealth Company Profile
Company profile explainedCompany Profile
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
Key Executives
| Name | Position |
|---|---|
| Erez Raphael | Chief Executive Officer & Director |
| Chen Franco-Yehuda | Chief Financial Officer, Treasurer & Secretary |
| Claudia Levi | Content & Communications Manager |
| Dov Oppenheim | Co-Founder & Production Chief |
| Kat Parrella | Investor Relations Manager |
| Lara Dodo | Chief Operations Officer |
| Mona Dean | Chief Compliance Officer |
| Omar Manejwala | Chief Medical Officer |
| Rob Halpern | SVP of Marketing |
| Steven C. Nelson | Consultant |
| Zoe Harrison | VP of Accounting & Corporate Development |
DarioHealth
| Country | United States |
| IPO Date | Mar 14, 2016 |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| Employees | 163 |
| CEO | Erez Raphael |
Contact Details
322 W. 57th Street New York City,
New York 10019 United States
Stock Details
| Ticker Symbol | DRIO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001533998 |
| CUSIP Number | 23725P308 |
| ISIN Number | US23725P3082 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove DRIO